Rubinfeld Roy S, Gum Glenwood G, Talamo Jonathan H, Parsons Edward C
CXL Ophthalmics, LLC, Encinitas, CA, USA.
Absorption Systems California, LLC, San Diego, CA, USA.
Clin Ophthalmol. 2021 May 11;15:1985-1994. doi: 10.2147/OPTH.S300886. eCollection 2021.
To evaluate effects of sodium iodide (NaI) on riboflavin concentration in corneal stroma before and during ultraviolet A (UVA) light exposure using a novel transepithelial corneal collagen crosslinking (CXL) procedure (EpiSmart CXL system, CXL Ophthalmics, Encinitas CA).
Riboflavin solutions with NaI (Ribostat, CXL Ophthalmics, Encinitas CA) and without NaI were used for CXL in rabbits using EpiSmart. A pilot study determined sufficient riboflavin loading time. Four rabbits were dosed and monitored. Riboflavin fluorescence intensity was assessed from masked slit-lamp photos. A 12 min loading time was selected. Sixteen additional rabbits received the two formulae in contralateral eyes for CXL. Riboflavin uptake was assessed at 0, 10, 15, 20, 25, and 30 min of UVA exposure using a scale for riboflavin fluorescence previously validated against stromal concentration. Post sacrifice, corneal stromal samples were analyzed for concentrations of riboflavin and riboflavin 5'-phosphate.
Eyes dosed with NaI riboflavin had higher riboflavin grades compared to eyes dosed with the NaI-free riboflavin formulation immediately after riboflavin loading and persisting throughout UVA exposure, with significantly higher ( < 0.01 to < 0.05) riboflavin grades from 15 through 25 min of UVA exposure. Riboflavin grades decreased more slowly in eyes dosed with NaI riboflavin through 25 minutes of UVA exposure. Minor conjunctival irritation was noted with or without NaI.
The addition of NaI to riboflavin solution is associated with increased riboflavin concentration in corneal stroma throughout a clinically relevant time course of UVA exposure. This effect may be a combination of enhanced epithelial penetration and reduced riboflavin photodegradation and should enhance intrastromal crosslinking.
使用一种新型的经上皮角膜胶原交联(CXL)程序(EpiSmart CXL系统,CXL眼科公司,加利福尼亚州恩西尼塔斯),评估碘化钠(NaI)对紫外线A(UVA)照射前及照射期间角膜基质中核黄素浓度的影响。
使用含NaI的核黄素溶液(Ribostat,CXL眼科公司,加利福尼亚州恩西尼塔斯)和不含NaI的核黄素溶液,通过EpiSmart对兔进行CXL。一项初步研究确定了足够的核黄素加载时间。对4只兔子给药并进行监测。从遮盖的裂隙灯照片评估核黄素荧光强度。选择12分钟的加载时间。另外16只兔子在对侧眼接受两种配方进行CXL。使用先前根据基质浓度验证的核黄素荧光量表,在UVA照射的0、10、15、20、25和30分钟评估核黄素摄取。处死后,分析角膜基质样本中核黄素和核黄素5'-磷酸的浓度。
与加载核黄素后立即以及在整个UVA照射期间给予不含NaI的核黄素配方的眼睛相比,给予含NaI核黄素的眼睛具有更高的核黄素等级,在UVA照射15至25分钟时核黄素等级显著更高(<0.01至<0.05)。在UVA照射25分钟内,给予含NaI核黄素的眼睛中核黄素等级下降更缓慢。无论有无NaI,均观察到轻微的结膜刺激。
在核黄素溶液中添加NaI与在UVA照射的临床相关时间过程中角膜基质中核黄素浓度增加有关。这种效应可能是上皮渗透性增强和核黄素光降解减少的综合结果,并且应该会增强基质内交联。